Moleculin Reports First Quarter 2024 Financial Results and Provides Corporate Update

/PRNewswire/ — Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company with a broad portfolio of drug…
Share This Post
Related Articles

How AI is empowering tech leaders

AI is revolutionizing procurement by automating routine tasks, improving decision-making, and enhancing efficiency. It’s also enhancing strategic procurement, helping procurement teams drive long-term value for their organizations.

Read More

The PTS Blog

Subscribe to our blog to stay up to date on the latest HCM, Data, Recruiting, Technology, and Software trends.

Top Posts From PTS
Explore

View our White Papers

View our Case Studies

Receive the latest updates

Subscribe To
Our Quarterly Newsletter

Get notified about new blog posts, case studies, white papers, and more!